Health-related quality of life after second-line axi-cel in transplant-ineligible patients with large B-cell lymphoma. [PDF]
Charton E +27 more
europepmc +1 more source
Resistance mechanisms and overcoming strategies for CAR T-cell therapy in B-cell hematologic malignancies. [PDF]
Li P, Xue X, Zhang Z.
europepmc +1 more source
Integrating new and "old" cellular therapies in the evolving landscape of relapsed or refractory large B-cell lymphoma. [PDF]
Amaducci E +9 more
europepmc +1 more source
Ibrutinib exposure correlates with improved efficacy of CAR T cells in patients with mantle cell lymphoma. [PDF]
Darnell EP +11 more
europepmc +1 more source
Axicabtagene ciloleucel in combination with rituximab for refractory large B cell lymphoma: the phase 2, single-arm ZUMA-14 trial. [PDF]
Strati P +14 more
europepmc +1 more source
Editorial: Benign paroxysmal positional vertigo
Anita Bhandari +4 more
doaj +1 more source
Early steroid and anakinra use to manage axicabtagene ciloleucel toxicity reduces the total duration of CRS and ICANS. [PDF]
Wang WL +22 more
europepmc +1 more source

